These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6376905)

  • 21. Beneficial effect of captopril in a patient with congestive heart failure and ischemic interventricular septal rupture.
    Cintrón G; Rivera del Río JR; Aranda JM; Hernández-López E; Linares E; Ramírez EA
    Bol Asoc Med P R; 1983 Feb; 75(2):73-4. PubMed ID: 6347216
    [No Abstract]   [Full Text] [Related]  

  • 22. New strategies in the management of severe chronic heart failure: captopril.
    Am Heart J; 1982 Nov; 104(5 Pt 2):1125-228. PubMed ID: 6753548
    [No Abstract]   [Full Text] [Related]  

  • 23. Azotemia in patients with congestive heart failure treated with captopril.
    Pierpont GL; Levine TB; Cohn JN
    Minn Med; 1983 Apr; 66(4):223-5. PubMed ID: 6343832
    [No Abstract]   [Full Text] [Related]  

  • 24. [Enhancement of the effect of captopril in the 1st 48 hours of treating refractory heart failure. A comparison with intravenous trinitrine].
    Le Pailleur C; Baubion N; Metzger JP; Heulin A; Vacheron A; Di Matteo J
    Arch Mal Coeur Vaiss; 1984 Jun; 77(6):700-6. PubMed ID: 6431936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Captopril--a new treatment for severe congestive heart failure.
    Kendall MJ; Smith SR; Thomson MH
    J Clin Hosp Pharm; 1982 Dec; 7(4):231-44. PubMed ID: 6761368
    [No Abstract]   [Full Text] [Related]  

  • 26. [Acute hemodynamic and coronary effects of captopril in chronic cardiac failure].
    Ourbak P; Pornin M; Melanidis J; Bouziri S; Allal J; Sellier P; Maurice P
    Arch Mal Coeur Vaiss; 1984 Aug; 77(8):865-71. PubMed ID: 6435565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New approaches to managing congestive heart failure.
    Romankiewicz N
    J Pract Nurs; 1983 Jan; 33(1):13-7. PubMed ID: 6338208
    [No Abstract]   [Full Text] [Related]  

  • 28. Factors predicting acute and long-term response to captopril therapy in congestive heart failure.
    Levine TB; Cohn JN
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):169S-174S. PubMed ID: 6753898
    [No Abstract]   [Full Text] [Related]  

  • 29. Captopril therapy in chronic congestive heart failure.
    Yadav BS; Kaul UA; Manoharan S; Bahl VK; Khanna CM; Khalilullah M
    Indian Heart J; 1985; 37(6):390-3. PubMed ID: 3915492
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
    Kramer B; Topic N; Massie B
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):143S-151S. PubMed ID: 6753895
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of captopril on pulmonary arterial hypertension in congestive heart failure associated with chronic obstructive bronchopneumopathy].
    Saadjian A; Philip-Joet F; Allard-Latour G; Arnaud A; Torresani J
    Rev Pneumol Clin; 1984; 40(5):321-5. PubMed ID: 6395282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute effects of angiotensin I converting enzyme inhibitor, captopril (SQ 14, 225) on severe heart failure--hemodynamics, plasma catecholamine levels, renin-angiotensin-aldosterone system and blood gas data (author's transl)].
    Morimoto Y; Baba M; Takahashi T; Fujii M; Konishi T; Kawanami C; Hamada M; Nakano T; Takezawa H
    Kokyu To Junkan; 1982 Mar; 30(3):317-25. PubMed ID: 6808624
    [No Abstract]   [Full Text] [Related]  

  • 34. Captopril (capoten) for heart failure.
    Med Lett Drugs Ther; 1982 Oct; 24(619):89-90. PubMed ID: 7050648
    [No Abstract]   [Full Text] [Related]  

  • 35. [Role of the renin-angiotensin system in the regulation of the vascular resistance of chronic heart failure (author's transl)].
    Noda H; Tokuyasu Y; Takahahashi S; Nakao H; Kimata S; Hirosawa K; Sugino N
    Kokyu To Junkan; 1981 Sep; 29(9):971-6. PubMed ID: 7034102
    [No Abstract]   [Full Text] [Related]  

  • 36. [Captopril (Capoten) in the treatment of heart insufficiency].
    Rømer FK
    Ugeskr Laeger; 1984 Feb; 146(6):445-7. PubMed ID: 6367180
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of captopril in left ventricular failure during the acute stage of myocardial infarction].
    Kayanakis JG; Breton J; Maillet J; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1983 Dec; 76(12):1369-74. PubMed ID: 6422872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertension and congestive heart failure: benefits of converting enzyme inhibition (captopril).
    Gavras H
    J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):518-20. PubMed ID: 6338084
    [No Abstract]   [Full Text] [Related]  

  • 39. Captopril in patients with terminal cardiac failure.
    Nicholls MG; Ikram H; Hull FT
    N Z Med J; 1982 Oct; 95(718):736-8. PubMed ID: 6755319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of rebound deterioration in cardiac function upon withdrawal of captopril for heart failure.
    Ikram H; Nicholls MG; Espiner EA; Maslowski AH
    Lancet; 1981 Apr; 1(8224):844. PubMed ID: 6111707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.